- Home
- TDOC
TDOC
Teladoc Health Inc.
as 07-26-2024 4:00pm EST
Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
Upcoming Earnings Alert:
Get ready for potential market movements as Teladoc Health Inc. TDOC prepares to release earnings report on 31 Jul 2024.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | PURCHASE |
| Market Cap: | 1.6B | IPO Year: | 2015 |
| Target Price: | $19.03 | AVG Volume (30 days): | 6.9M |
| Analyst Decision: | Hold | Number of Analysts: | 19 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.41 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.73 - $30.15 | Next Earning Date: | 07-31-2024 |
| Revenue: | $2,619,302,000 | Revenue Growth: | 6.01% |
| Revenue Growth (this year): | 4.21% | Revenue Growth (next year): | 3.61% |
Stock Insider Trading Activity of Teladoc Health Inc. (TDOC)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nanis Nikolaos P. | TDOC | Chief Technology Officer | Jul 1 '24 | Sell | $9.39 | 442 | $4,150.38 | 73,226 | SEC Form 4 |
| Trencher Daniel | TDOC | CHIEF STRATEGY OFFICER | May 31 '24 | Sell | $11.16 | 1,790 | $19,971.03 | 28,322 | SEC Form 4 |
| Waters Michael Willem | TDOC | CHIEF OPERATING OFFICER | May 31 '24 | Sell | $11.16 | 4,246 | $47,372.62 | 68,948 | SEC Form 4 |
| Raman-Tangella Vidya | TDOC | CHIEF MEDICAL OFFICER | May 31 '24 | Sell | $11.04 | 468 | $5,166.72 | 27,280 | SEC Form 4 |
| Raman-Tangella Vidya | TDOC | CHIEF MEDICAL OFFICER | May 31 '24 | Sell | $11.16 | 1,122 | $12,518.15 | 27,748 | SEC Form 4 |
| Raman-Tangella Vidya | TDOC | CHIEF MEDICAL OFFICER | May 31 '24 | Sell | $11.21 | 3,407 | $38,192.47 | 28,870 | SEC Form 4 |
| Turitz Andrew | TDOC | EVP, CORPORATE DEVELOPMENT | May 31 '24 | Sell | $11.16 | 1,627 | $18,152.44 | 37,659 | SEC Form 4 |
| Kornwasser Laizer | TDOC | PRESIDENT, ENTERPRISE GROWTH | May 31 '24 | Sell | $11.16 | 4,812 | $53,687.48 | 90,610 | SEC Form 4 |
| Cave James L. | TDOC | INTERIM CAO | May 31 '24 | Sell | $11.16 | 854 | $9,528.08 | 12,479 | SEC Form 4 |
| Verstraete Stephany | TDOC | CHIEF MARKETING OFFICER | May 31 '24 | Sell | $11.16 | 2,096 | $23,385.07 | 60,158 | SEC Form 4 |
| Nanis Nikolaos P. | TDOC | Chief Technology Officer | May 31 '24 | Sell | $11.16 | 1,040 | $11,603.28 | 72,435 | SEC Form 4 |
| Vandervoort Adam C | TDOC | CHIEF LEGAL OFFICER, SECRETARY | May 31 '24 | Sell | $11.16 | 4,015 | $44,795.36 | 41,264 | SEC Form 4 |
| Murthy Mala | TDOC | ACTING CEO, CFO | May 31 '24 | Sell | $11.16 | 8,807 | $98,259.70 | 78,713 | SEC Form 4 |
| Geshuri Arnnon | TDOC | CHIEF PEOPLE OFFICER | May 31 '24 | Sell | $11.16 | 1,807 | $20,160.70 | 41,686 | SEC Form 4 |
| Daniel Karen L | TDOC | Director | May 22 '24 | Sell | $11.90 | 9,834 | $117,024.60 | 36,995 | SEC Form 4 |
| Trencher Daniel | TDOC | CHIEF STRATEGY OFFICER | May 17 '24 | Sell | $12.83 | 1,000 | $12,830.00 | 25,192 | SEC Form 4 |
| Kornwasser Laizer | TDOC | PRESIDENT, ENTERPRISE GROWTH | May 1 '24 | Sell | $12.69 | 10,411 | $132,094.77 | 86,070 | SEC Form 4 |
| Waters Michael Willem | TDOC | CHIEF OPERATING OFFICER | May 1 '24 | Sell | $12.69 | 5,793 | $73,501.58 | 64,881 | SEC Form 4 |
| Raman-Tangella Vidya | TDOC | CHIEF MEDICAL OFFICER | May 1 '24 | Sell | $12.69 | 3,691 | $46,831.41 | 29,160 | SEC Form 4 |
| Trencher Daniel | TDOC | CHIEF STRATEGY OFFICER | Apr 17 '24 | Sell | $13.21 | 1,000 | $13,210.00 | 26,192 | SEC Form 4 |
| Nanis Nikolaos P. | TDOC | Chief Technology Officer | Apr 1 '24 | Sell | $14.31 | 461 | $6,598.75 | 70,621 | SEC Form 4 |
| Geshuri Arnnon | TDOC | CHIEF PEOPLE OFFICER | Mar 25 '24 | Sell | $15.06 | 7,500 | $112,950.00 | 38,470 | SEC Form 4 |
| Trencher Daniel | TDOC | CHIEF STRATEGY OFFICER | Mar 18 '24 | Sell | $15.18 | 1,000 | $15,180.00 | 27,192 | SEC Form 4 |
| Turitz Andrew | TDOC | EVP, CORPORATE DEVELOPMENT | Mar 5 '24 | Sell | $14.53 | 5,647 | $82,050.91 | 33,782 | SEC Form 4 |
| Kornwasser Laizer | TDOC | PRESIDENT, ENTERPRISE GROWTH | Mar 1 '24 | Sell | $14.52 | 18,349 | $266,354.08 | 76,283 | SEC Form 4 |
Latest Teladoc Health Inc. News
TDOC Breaking Stock News: Dive into TDOC Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note
GlobeNewswire
9 days ago
Teladoc Health to Announce Second Quarter 2024 Financial Results
Simply Wall St.
9 days ago
Great week for Teladoc Health, Inc. (NYSE:TDOC) institutional investors after losing 60% over the previous year
Hospital Management
10 days ago
Teladoc Health and Brightline launch comprehensive mental health services
MT Newswires
10 days ago
Teladoc, Brightline to Offer Virtual Pediatric Mental Health Services
GlobeNewswire
11 days ago
Teladoc Health Introduces Pediatric, Adolescent and Family Mental Healthcare Through Partnership with Brightline
Motley Fool
12 days ago
2 Healthcare Stocks to Buy at a Discount
Zacks
14 days ago
Teladoc (TDOC) Ascends But Remains Behind Market: Some Facts to Note
Compare TDOC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TDOC Teladoc Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.